COSTA MESA, Calif., Feb. 19, 2020 /PRNewswire/ -- As the CBD industry grows exponentially, one huge problem has plagued consumers: There's no standard way to predict what dosage, delivery mechanism and concentration will deliver optimal effects.
Many have attempted to use the trial and error method in order to determine what works best. Unfortunately, such an approach is expensive, time-consuming and potentially dangerous -- as it fails to take into account possible drug interactions, especially when taken with other prescription medication.
New Coastal has teamed up with Endocanna Health, a leading biotechnology research company, to offer the first-of-its-kind CBD DNA test. The test helps consumers take the guesswork out of taking CBD.
"Each of us has a DNA makeup that is 99.9% similar to everyone else's -- but it's that 0.1% unique quantity that can make a huge difference," Endocanna CEO Len May said. "Cannabis is complex. That seemingly small DNA difference is critically important -- it's responsible for your individual experience with cannabinoids and CBD."
The CBD DNA test is based on the breakthrough idea that each person has a unique endo-compatibility profile that makes some CBD products more ideal to take than others.
The endocannabinoid system, or ECS, is a bodily system made up of neurotransmitters that bind to cannabinoid receptors (endocannabinoids) and cannabinoid receptor proteins. Cannabinoid receptor proteins are located across the vertebrate central nervous system and peripheral nervous system.
New Coastal's endocannabinoid CBD DNA test reveals:
This test aligns with New Coastal's commitment to leading the industry with personalized CBD solutions. The test can be completed in three simple steps:
In addition to providing optimal dosage information, test results demystify:
Stress and Anxiousness:
Mood disturbances and feelings of depression:
To learn more about DNA testing, the endocannabinoid system and how each body reacts to CBD, visit https://newcoastal.shop/product/cbd-dna-test-kit/.
About New Coastal Group, Inc.: New Coastal Group, Inc. provides premium CBD products that promote a healthy lifestyle and overall wellness. New Coastal Group also offers a unique DNA test that identifies the exact CBD product that will provide the optimal level of wellness for each individual person. New Coastal Group is delivering on the promise of CBD to the hundreds of millions of Americans who can benefit from taking it daily. By offering best-in-class CBD-infused products for a fair and affordable price, Coastal is on a mission to ease pain and suffering, improve beauty and quality of life and help tackle the worldwide opioid crisis.
About Endocanna Health™, Inc.
Endocanna is a biotechnology research company that utilizes a patent-pending process for its cannabinoid DNA variant report, Endo·Decoded™ and product matching algorithm, Endo·Aligned™. Endo·dna™ provides two ways to submit DNA for analysis, either collected through a simple saliva swab or a direct upload of genetic data files from popular DNA testing services like Ancestry, 23andMe, Family TreeDNA, or MyHeritageDNA. Endocanna's HIPAA compliant and secure health and wellness portal, Mydna.live, provides customers with a personalized experience where they can access their Endo·Decoded report and Endo·Aligned formulation suggestions for their specific genotype.
For more information, visit:
Facebook: Endocanna Health
Contact: Fred Bloom
Phone: (949) 339-5500
View original content to download multimedia:http://www.prnewswire.com/news-releases/new-coastal-group-debuts-breakthrough-dna-test-that-identifies-the-optimal-cbd-products-for-every-individual-301007976.html